Immuno-PET Imaging of Siglec-15 Using the Zirconium-89-Labeled Therapeutic Antibody, NC318
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immuno-PET Imaging of Siglec-15 Using the Zirconium-89-Labeled Therapeutic Antibody, NC318
Authors
Keywords
-
Journal
Molecular Imaging
Volume 2023, Issue -, Pages 1-18
Publisher
Hindawi Limited
Online
2023-02-10
DOI
10.1155/2023/3499655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
- (2022) Nisha Kumari et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Development of an immunohistochemical assay for Siglec-15
- (2022) Saba Shafi et al. LABORATORY INVESTIGATION
- Siglec‐15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44
- (2021) Weitao Liu et al. FEBS LETTERS
- Molecular structure, expression, and the emerging role of Siglec‐15 in skeletal biology and cancer
- (2021) Sarah Rashid et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Siglec Signaling in the Tumor Microenvironment
- (2021) Eline J. H. van Houtum et al. Frontiers in Immunology
- Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis
- (2021) Danzan Mansorunov et al. Diagnostics
- The diverse functions of Siglec-15 in bone remodeling and antitumor responses
- (2020) Fu-biao Kang et al. PHARMACOLOGICAL RESEARCH
- Siglec-15-targeting therapy protects against glucocorticoid-induced osteoporosis of growing skeleton in juvenile rats
- (2020) Dai Sato et al. BONE
- Siglec-15 as an emerging target for next-generation cancer immunotherapy
- (2020) Jingwei Sun et al. CLINICAL CANCER RESEARCH
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy
- (2018) Neha Kamran et al. CLINICAL IMMUNOLOGY
- A Preclinical Assessment of 89Zr-atezolizumab Identifies a Requirement for Carrier Added Formulations Not Observed with 89Zr-C4
- (2018) Anna Moroz et al. BIOCONJUGATE CHEMISTRY
- Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth
- (2018) Dai Sato et al. BONE
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Identification of Siglec Ligands Using a Proximity Labeling Method
- (2017) Lanyi Chang et al. JOURNAL OF PROTEOME RESEARCH
- The Role of Sialyl-Tn in Cancer
- (2016) Jennifer Munkley INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption
- (2014) Matthew Stuible et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immuno-PET Imaging of Tumor Endothelial Marker 8 (TEM8)
- (2014) Frank Kuo et al. MOLECULAR PHARMACEUTICS
- From Murine to Human Nude/SCID: The Thymus, T-Cell Development and the Missing Link
- (2012) Rosa Romano et al. Clinical & Developmental Immunology
- The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF- secretion from monocytes/macrophages through the DAP12-Syk pathway
- (2012) R. Takamiya et al. GLYCOBIOLOGY
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- RADAR Realistic Animal Model Series for Dose Assessment
- (2010) M. A. Keenan et al. JOURNAL OF NUCLEAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started